Measures of cholesterol concentration in 72 participants treated
with three different drugs. The aim is to examine the potential of new class
of drugs in lowering the cholesterol concentration and consequently reducing
heart attack.
The participants include 36 males and 36 females. Males and
females were further (equally) subdivided into whether they were at low or
high risk of heart attack.
This data set is suited for three way Anova test.
It contain the following variables:
gender, which has two
categories: "male" and "female";
risk which has two levels: "low" and
"high"
drug, which has three categories: "A", "B" and "C".